EMDA vs BCG for bladder cancer treatment
JS Medical will be exhibiting the EMDA® drug delivery system at BAUS Brighton.
Latest Data from Guy’s Trial Endorses EMDA
Latest data from Guy’s & St Thomas’ endorses intravesical sequential BCG/EMDA+MMC for HR-NMIBC
Dr Carlo Brigouri Talks About RenalGuard REMEDIAL III Trial
Interview by Dr C. Michael Gibson at TCT2019 in San Francisco
Trial finds RenalGuard Therapy® superior to POSEIDON method
REMEDIAL III trial results presented at TCT2019 in San Franciso by Dr Carlo Briguori.
JS Medical named RenalGuard’s new UK Distributor
RenalGuard Solutions has appointed JS Medical as their new UK and Ireland distributor.
Are you at CIRSE2019 in Barcelona?
Murat Celebi is busy meeting innovative MedTech companies at CIRSE2019
EMDA®+MMC to plug BCG shortage
BAUS, EAU and NICE have suggested that hospitals switch to our EMDA®+Mitomycin-C treatment due to the worldwide shortage of BCG.
Are you attending BAUS 2019?
We are counting down to BAUS 2019 in Glasgow next week.
RenalGuard at EuroPCR 2019
EuroPCR 2019 proved as informative as ever with Robin Luper delighted to share the benefits of the RenalGuard System™ with new contacts as well as catching up with colleagues.
Physion Appoints JS Consulting in MENA
Physion has appointed JS Consulting as their strategic advisor for the GCC & Middle East regions.